{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:42Z","timestamp":1793413482153,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In recent years, China has experienced a rapid increase in the number of pertussis cases among children aged 5 to 9. We conducted this phase 4 randomized, controlled trial (NCT05870631) in Zhejiang Province, China, to compare the immunogenicity and safety of co-purified diphtheria, tetanus, and acellular pertussis combined vaccine (co-purified DTaP) to diphtheria and tetanus combined vaccine (DT) in 6-year-old children. Between April 2023 to July 2023, 480 participants were randomized to receive one dose of co-purified DTaP (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009240) or DT (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009240). 28 days after vaccination, the seroconversion rates of the co-purified DTaP were 81.20% for anti-PT and 74.36% for anti-FHA, and achieved a significantly higher rate for anti-tetanus compared to the DT vaccine (97.01% vs. 87.05%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). Both vaccines showed 100% seroconversion for anti- diphtheria antibody. For all antibody types, the co-purified DTaP can induced higher geometric mean concentrations. More vaccine-related adverse events were reported with the co-purified DTaP. Most of the severity occurred in Grade 1 and 2. The booster dose of co-purified DTaP vaccination is safe and induces a significant anti-pertussis antibody response, it may be feasible to give a booster dose of co-purified DTaP instead of the recommended DT for 6-year-old children in China.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-66890-7","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T19:26:54Z","timestamp":1764444414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunogenicity and safety of co-purified diphtheria, tetanus and acellular pertussis vaccine in 6-year-old Chinese children"],"prefix":"10.1038","volume":"17","author":[{"given":"Xuewen","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0863-5177","authenticated-orcid":false,"given":"Hanqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"66890_CR1","unstructured":"Organization WH. Health topics, pertussis. https:\/\/www.who.int\/health-topics\/pertussis#tab=tab_1 (2024)."},{"key":"66890_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/PCC.0000000000000851","volume":"17","author":"L Straney","year":"2016","unstructured":"Straney, L. et al. Burden and outcomes of severe pertussis infection in critically Ill infants. Pediatr. Crit. Care Med. 17, 735\u2013742 (2016).","journal-title":"Pediatr. Crit. Care Med."},{"key":"66890_CR3","doi-asserted-by":"crossref","unstructured":"Hu, Y., Wang, L., Yao, K. & Wang, Q. Atypical surge of hospitalized and severe cases of pertussis: A single center 19-years study from China. Pulmonology 30, 636\u2013638(2024).","DOI":"10.1016\/j.pulmoe.2024.06.006"},{"key":"66890_CR4","doi-asserted-by":"publisher","first-page":"S310","DOI":"10.1093\/infdis\/jiaa469","volume":"224","author":"MD Decker","year":"2021","unstructured":"Decker, M. D. & Edwards, K. M. Pertussis (Whooping Cough).  J. Infect. Dis. 224, S310\u2013s320 (2021).","journal-title":"J. Infect. Dis."},{"key":"66890_CR5","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1001\/jama.2024.22533","volume":"332","author":"R Rubin","year":"2024","unstructured":"Rubin, R. Pertussis cases are surging this year-here\u2019s why. Jama 332, 1597\u20131598 (2024).","journal-title":"Jama"},{"key":"66890_CR6","doi-asserted-by":"publisher","first-page":"q2114","DOI":"10.1136\/bmj.q2114","volume":"386","author":"JH Tanne","year":"2024","unstructured":"Tanne, J. H. Whooping cough: Fivefold rise in US cases spells return to pre-pandemic levels. BMJ 386, q2114 (2024).","journal-title":"BMJ"},{"key":"66890_CR7","doi-asserted-by":"publisher","first-page":"q1059","DOI":"10.1136\/bmj.q1059","volume":"385","author":"Z Kmietowicz","year":"2024","unstructured":"Kmietowicz, Z. Whooping cough: Five infants die in England this year as cases continue to rise. BMJ 385, q1059 (2024).","journal-title":"BMJ"},{"key":"66890_CR8","doi-asserted-by":"publisher","unstructured":"Rodrigues, C. et al. Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024. Euro Surveill. 29, https:\/\/doi.org\/10.2807\/1560-7917.es.2024.29.31.2400459 (2024).","DOI":"10.2807\/1560-7917.es.2024.29.31.2400459"},{"key":"66890_CR9","doi-asserted-by":"publisher","unstructured":"Poltorak, V. et al. Increase of pertussis cases in the Vall\u00e8s region, Catalonia, Spain, September 2023 to April 2024. Euro Surveill. 29, https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.24.2400332 (2024).","DOI":"10.2807\/1560-7917.ES.2024.29.24.2400332"},{"key":"66890_CR10","doi-asserted-by":"publisher","unstructured":"Nordholm, A. C. et al. Pertussis epidemic in Denmark, August 2023 to February 2024. Euro Surveill 29, https:\/\/doi.org\/10.2807\/1560-7917.es.2024.29.14.2400160 (2024).","DOI":"10.2807\/1560-7917.es.2024.29.14.2400160"},{"key":"66890_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106232","volume":"89","author":"S Cho","year":"2024","unstructured":"Cho, S., Kim, D. W., Achangwa, C., Oh, J. & Ryu, S. Pertussis in the elderly: Plausible amplifiers of persistent community transmission of pertussis in South Korea.  J. Infect. 89, 106232 (2024).","journal-title":"J. Infect."},{"key":"66890_CR12","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmi.2024.08.016","volume":"30","author":"P Fu","year":"2024","unstructured":"Fu, P. et al. Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China. Clin. Microbiol. Infect. 30, 1439\u20131446 (2024).","journal-title":"Clin. Microbiol. Infect."},{"key":"66890_CR13","doi-asserted-by":"publisher","first-page":"2389086","DOI":"10.1080\/22221751.2024.2389086","volume":"13","author":"H Yahong","year":"2024","unstructured":"Yahong, H., Mengyang, G., Meng, Q., Yu, D. & Kaihu, Y. Rising pertussis cases and deaths in China: current trends and clinical solutions. Emerg. Microbes Infect. 13, 2389086 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"66890_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106289","volume":"89","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Yu, D., Wang, K. & Ye, Q. Global resurgence of pertussis: A perspective from China.  J. Infect. 89, 106289 (2024).","journal-title":"J. Infect."},{"key":"66890_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106140","volume":"88","author":"G Mengyang","year":"2024","unstructured":"Mengyang, G., Yahong, H., Qinghong, M., Wei, S. & Kaihu, Y. Resurgence and atypical patterns of pertussis in China.  J. Infect. 88, 106140 (2024).","journal-title":"J. Infect."},{"key":"66890_CR16","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1016\/j.vaccine.2022.10.020","volume":"40","author":"H He","year":"2022","unstructured":"He, H. et al. The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study. Vaccine 40, 6956\u20136962 (2022).","journal-title":"Vaccine"},{"key":"66890_CR17","doi-asserted-by":"publisher","first-page":"374","DOI":"10.46234\/ccdcw2023.071","volume":"5","author":"P Zhu","year":"2023","unstructured":"Zhu, P. et al. Effectiveness of DTaP Against Pertussis in \u22642-Year-Old Children - Linyi Prefecture, Shandong Province, China, 2017-2019. China CDC Wkly. 5, 374\u2013378 (2023).","journal-title":"China CDC Wkly."},{"key":"66890_CR18","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1542\/peds.2004-2759","volume":"116","author":"KM Bisgard","year":"2005","unstructured":"Bisgard, K. M. et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 116, e285\u2013e294 (2005).","journal-title":"Pediatrics"},{"key":"66890_CR19","unstructured":"Pertussis vaccines: WHO position paper - September 2015. Wkly. Epidemiol. Rec. 90, 433\u2013458 (2015)."},{"key":"66890_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4161\/21645515.2014.988549","volume":"11","author":"Y Xu","year":"2015","unstructured":"Xu, Y. et al. Characterization of co-purified acellular pertussis vaccines. Hum.Vaccin. Immunother. 11, 421\u2013427 (2015).","journal-title":"Hum.Vaccin. Immunother."},{"key":"66890_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","volume":"69","author":"FP Havers","year":"2020","unstructured":"Havers, F. P., Moro, P. L., Hunter, P., Hariri, S. & Bernstein, H. Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the advisory committee on immunization practices - United States, 2019. MMWR Morbidity Mortal. Wkly. Rep. 69, 77\u201383 (2020).","journal-title":"MMWR Morbidity Mortal. Wkly. Rep."},{"key":"66890_CR22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1586\/14760584.7.5.621","volume":"7","author":"CA Gidengil","year":"2008","unstructured":"Gidengil, C. A., Sandora, T. J. & Lee, G. M. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA. Expert Rev. Vaccin. 7, 621\u2013634 (2008).","journal-title":"Expert Rev. Vaccin."},{"key":"66890_CR23","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1080\/21645515.2015.1046662","volume":"11","author":"D MacDougall","year":"2015","unstructured":"MacDougall, D. et al. Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know. Hum. Vaccin. Immunother. 11, 2167\u20132179 (2015).","journal-title":"Hum. Vaccin. Immunother."},{"key":"66890_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3345\/kjp.2011.54.4.141","volume":"54","author":"KM Choi","year":"2011","unstructured":"Choi, K. M. et al. Recommendation for the use of newly introduced Tdap vaccine in Korea. Korean J. Pediatrics 54, 141\u2013145 (2011).","journal-title":"Korean J. Pediatrics"},{"key":"66890_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106194","volume":"89","author":"Y Liu","year":"2024","unstructured":"Liu, Y. & Ye, Q. Resurgence and the shift in the age of peak onset of pertussis in southern China.  J. Infect. 89, 106194 (2024).","journal-title":"J. Infect."},{"key":"66890_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106272","volume":"89","author":"F Liu","year":"2024","unstructured":"Liu, F., Li, Z., Hu, Y., Jia, B. & Ma, J. The recent rapid rise in pertussis in Chaoyang District, Beijing: Improved recognition and diagnostic capabilities.  J. Infect. 89, 106272 (2024).","journal-title":"J. Infect."},{"key":"66890_CR27","doi-asserted-by":"publisher","first-page":"2417532","DOI":"10.1080\/21645515.2024.2417532","volume":"20","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. Seroepidemiology of pertussis immunity in five provinces of China: A population-based, cross-sectional study. Hum. Vaccin. Immunother. 20, 2417532 (2024).","journal-title":"Hum. Vaccin. Immunother."},{"key":"66890_CR28","doi-asserted-by":"publisher","unstructured":"Dai, H. et al. Underestimated Incidence Rate of Pertussis in the Community: Results from Active Population-Based Surveillance in Yiwu, China. Microorganisms 12, https:\/\/doi.org\/10.3390\/microorganisms12112186 (2024).","DOI":"10.3390\/microorganisms12112186"},{"key":"66890_CR29","doi-asserted-by":"publisher","first-page":"2341454","DOI":"10.1080\/21645515.2024.2341454","volume":"20","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysis. Hum. Vaccin.s Immunother. 20, 2341454 (2024).","journal-title":"Hum. Vaccin.s Immunother."},{"key":"66890_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126162","volume":"42","author":"J Ren","year":"2024","unstructured":"Ren, J. et al. Evaluation of pre-school pertussis booster vaccination in Shanghai, China: A cost-effectiveness analysis. Vaccine 42, 126162 (2024).","journal-title":"Vaccine"},{"key":"66890_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1055677","volume":"13","author":"Z Yin","year":"2022","unstructured":"Yin, Z. et al. Comparing the pertussis antibody levels of healthy children immunized with four doses of DTap-IPV\/Hib (Pentaxim) combination vaccine and DTaP vaccine in Quzhou, China. Front. Immunol. 13, 1055677 (2022).","journal-title":"Front. Immunol."},{"key":"66890_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jinf.2015.11.004","volume":"72","author":"M Clarke","year":"2016","unstructured":"Clarke, M. et al. The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis.  J. Infect. 72, 171\u2013178 (2016).","journal-title":"J. Infect."},{"key":"66890_CR33","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10096-022-04453-0","volume":"41","author":"LT Brandal","year":"2022","unstructured":"Brandal, L. T. et al. Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019. Eur. J. Clin. Microbiol. Infect. Dis. 41, 913\u2013924 (2022).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"66890_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01074-14","volume":"5","author":"MJ Bart","year":"2014","unstructured":"Bart, M. J. et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. mBio 5, e01074 (2014).","journal-title":"mBio"},{"key":"66890_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2025.101628","volume":"60","author":"J Cai","year":"2025","unstructured":"Cai, J. et al. Waning immunity, prevailing non-vaccine type ptxP3 and macrolide-resistant strains in the 2024 pertussis outbreak in China: a multicentre cross-sectional descriptive study.  Lancet Regional Health West. Pac. 60, 101628 (2025).","journal-title":"Lancet Regional Health West. Pac."},{"key":"66890_CR36","doi-asserted-by":"publisher","first-page":"2447611","DOI":"10.1080\/22221751.2024.2447611","volume":"14","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. Genomic epidemiology and evolution of Bordetella pertussis under the vaccination pressure of acellular vaccines in Beijing, China, 2020\u20132023. Emerg. Microbes Infect. 14, 2447611 (2025).","journal-title":"Emerg. Microbes Infect."},{"key":"66890_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coi.2019.03.006","volume":"59","author":"P Kapil","year":"2019","unstructured":"Kapil, P. & Merkel, T. J. Pertussis vaccines and protective immunity. Curr. Opin. Immunol. 59, 72\u201378 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"66890_CR38","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1016\/j.vaccine.2006.04.001","volume":"24","author":"S Black","year":"2006","unstructured":"Black, S., Friedland, L. R., Schuind, A. & Howe, B. Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years. Vaccine 24, 6163\u20136171 (2006).","journal-title":"Vaccine"},{"key":"66890_CR39","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1542\/peds.105.1.e11","volume":"105","author":"ME Pichichero","year":"2000","unstructured":"Pichichero, M. E. et al. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics 105, e11 (2000).","journal-title":"Pediatrics"},{"key":"66890_CR40","doi-asserted-by":"publisher","first-page":"905634","DOI":"10.3389\/fimmu.2022.905634","volume":"13","author":"X Sun","year":"2022","unstructured":"Sun, X. et al. Immunogenicity and safety of concomitant administration of the chinese inactivated poliovirus vaccine with the diphtheria-tetanus-acellular pertussis (DTaP) vaccine in children: A multicenter, randomized, non-inferiority, controlled trial. Front. Immunol. 13, 905634 (2022).","journal-title":"Front. Immunol."},{"key":"66890_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijid.2023.10.006","volume":"137","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in China. Int. J. Infect. Dis. 137, 9\u201315 (2023).","journal-title":"Int. J. Infect. Dis."},{"key":"66890_CR42","doi-asserted-by":"publisher","unstructured":"Zhu, F. et al. Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix()). Hum. Vaccin. 6, https:\/\/doi.org\/10.4161\/hv.6.3.10503 (2010).","DOI":"10.4161\/hv.6.3.10503"},{"key":"66890_CR43","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1080\/22221751.2022.2053364","volume":"11","author":"A Knuutila","year":"2022","unstructured":"Knuutila, A. et al. Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups. Emerg. Microbes Infect. 11, 956\u2013963 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"66890_CR44","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.vaccine.2006.09.053","volume":"25","author":"JM Langley","year":"2007","unstructured":"Langley, J. M. et al. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine. Vaccine 25, 1121\u20131125 (2007).","journal-title":"Vaccine"},{"key":"66890_CR45","unstructured":"Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 49, 1\u20138 (2000)."},{"key":"66890_CR46","first-page":"470","volume":"30","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Surveillance of adverse events following immunization in China, 2021-2022. Chin. J. Vaccin. Immun. 30, 470\u2013484 (2024).","journal-title":"Chin. J. Vaccin. Immun."},{"key":"66890_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1468-1331.2011.03445.x","volume":"19","author":"Z Ar\u00e1nyi","year":"2012","unstructured":"Ar\u00e1nyi, Z., Kov\u00e1cs, T., Sipos, I. & Bereczki, D. Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur. J. Neurol. 19, 15\u201320.e11-13 (2012).","journal-title":"Eur. J. Neurol."},{"key":"66890_CR48","doi-asserted-by":"publisher","first-page":"2261199","DOI":"10.1080\/21645515.2023.2261199","volume":"19","author":"M Pan","year":"2023","unstructured":"Pan, M., Sun, T., Zhu, W., Liu, H. & Dong, H. Guillain Barr\u00e9 syndrome after combined diphtheria, tetanus, and acellular pertussis (DTaP) vaccine: A rare pediatric case report and review of literature. Hum. Vaccin. Immunother. 19, 2261199 (2023).","journal-title":"Hum. Vaccin. Immunother."},{"key":"66890_CR49","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1016\/j.vaccine.2009.05.036","volume":"27","author":"WK Yih","year":"2009","unstructured":"Yih, W. K. et al. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine 27, 4257\u20134262 (2009).","journal-title":"Vaccine"},{"key":"66890_CR50","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.vaccine.2010.11.056","volume":"29","author":"JD Nordin","year":"2011","unstructured":"Nordin, J. D., Yih, W. K., Kulldorff, M. & Weintraub, E. Tdap and GBS letter. Vaccine 29, 1122 (2011).","journal-title":"Vaccine"},{"key":"66890_CR51","unstructured":"Administration NDCAP. Notice regarding adjustments to the immunization schedule for DTaP and DT vaccines under the national immunization program.https:\/\/www.ndcpa.gov.cn\/jbkzzx\/c100014\/common\/content\/content_1872098276166717440.html (2025)."},{"key":"66890_CR52","doi-asserted-by":"publisher","unstructured":"Gregg, K. A. & Merkel, T. J. Pertussis Toxin: A Key Component in Pertussis Vaccines? Toxins 11, https:\/\/doi.org\/10.3390\/toxins11100557 (2019).","DOI":"10.3390\/toxins11100557"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66890-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66890-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66890-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:04:13Z","timestamp":1767801853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66890-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66890"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66890-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.X., L.L., H.P., and Y.T.Z. are employees of the China National Biotec Group Company Limited. J.Z. and D.Z. are employees of the Wuhan Institute of Biological Products Company Limited. S.L. and W.Z. are employees of the Chengdu Institute of Biological Products Company Limited. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}